Abstract
Purpose of Review
Mycoplasma, economically important pathogens in livestock, often establishes immunologically complex persistent infections that drive their pathogenesis and complicate prophylaxis and therapy of the caused diseases. In this review, we summarize some of the recent findings concerning cellular and molecular persistence mechanisms related to the pathogenesis of mycoplasma infections in livestock.
Recent Findings
Data from recent studies prove several mechanisms including intracellular lifestyle, immune dysregulation, and autoimmunity as well as microcolony and biofilm formation and apoptosis of different host cell types as important persistence mechanisms in several clinically significant Mycoplasma species, i.e., M. bovis, M. gallisepticum, M. hyopneumoniae, and M. suis.
Summary
Evasion of the immune system and the establishment of persistent infections are key features in the pathogenesis of livestock mycoplasmas. In-depth knowledge of the underlying mechanisms will provide the basis for the development of therapy and prophylaxis strategies against mycoplasma infections.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Immune dysregulation, immune evasion, cell invasion, or biofilm formation is part of a sophisticated strategy, which enables mycoplasmas to establish persistent and chronic infections.
Mycoplasmas are characterized by the lack of a cell wall, resistance to ß-lactam antibiotics, low G + C content, and extremely small genome sizes connected with a highly limited metabolic capacity. Striking features of pathogenic Mycoplasma species include a strict parasitic and host-specific lifestyle (either extracellularly on epithelial cells or erythrocytes or intracellularly in different host cells), a high metabolic adaption to the host’s metabolism, and their fastidious nature (high demands on culture conditions) or even a found unculturability in vitro in hemotrophic mycoplasmas [1, 2].
Mycoplasma infections in livestock are known as a significant cause of economic loss and welfare concern in the agricultural sector worldwide. Both, primary pathogenic and facultatively pathogenic Mycoplasma species are involved. The economic impact is on the one hand the result of the clinical signs caused by the mycoplasmas themselves and on the other hand due to the increased susceptibility to other infectious agents caused by the infection-induced immune dysregulation [3]. Therapy and prophylaxis are not easy due to the common persistence of Mycoplasma infections and their complex pathogenesis. As a result, endemic infectious diseases are combated by the metaphylactic use of antibiotics posing a significant problem in the livestock sector concerning the high amount of used antimicrobial substances and the development of antibiotic resistance [4,5,6,7].
In livestock, the most relevant pathogenic species are M. bovis and M. mycoides subspecies mycoides in cattle; M. agalactiae, M. capricolum, and M. mycoides ssp. capri in small ruminants; M. hyopneumoniae in pigs; and M. gallisepticum in poultry. In addition, facultative pathogens like M. hyorhinis and M. hyosynoviae in pigs or M. synoviae in poultry are also connected to large economic losses in farms [8,9,10]. Clinical manifestations range from respiratory diseases to mastitis, arthritis, polyserositis, agalactia, and reproductive disorders (Table 1) [8, 10, 34, 35]. Furthermore, a highly specialized group of bacteria with a unique cell tropism to red blood cells (RBCs) was reclassified to the genus Mycoplasma as so-called hemotrophic mycoplasmas (trivially named hemoplasmas) at the beginning of the twentieth century [25, 36]. Hemotrophic mycoplasmas in livestock comprise M. suis, M. parvum, and ‘Candidatus M. haemosuis’ in pigs, M. wenyonii and ‘Ca. M. haemobos’ in cattle as well as M. ovis and ‘Ca. M. haemovis’ in sheep and goats (Table 1) [1, 13, 27,28,29,30, 37, 38]. The clinical outcome of hemoplasma infections is highly variable ranging from life-threatening anemia to various chronic syndromes (e.g., mild anemia, poor performance, reproductive disorders) or even asymptomatic courses [1, 26]. Economic significance was particularly described for M. suis, the causative agent of infectious anemia in pigs (IAP) due to its high prevalence and its chronic immunosuppressive nature [1, 39].
Mycoplasma-related infectious diseases are as aforementioned multifactorial and often associated with other viral or bacterial infections [1, 40, 41]. But also, abiotic factors (e.g., stress, crowding, housing condition, climate) influence the susceptibility of the hosts and the clinical outcome of the diseases. This complexity is also reflected on the level of the molecular pathogenesis since clinical signs and pathomorphological changes are not primarily caused by the direct damage of the host by the bacterium itself (e.g., by classic virulence factors such as toxins) but also by the host’s defense against the mycoplasmas [2, 42]. It is well known that Mycoplasma-infected animals develop both extensive innate and adaptive immune response to fight against infection. However, this immune response often fails to eliminate the pathogens leading to persistence and chronicity. Moreover, the induction of persistent lifelong infections in humans and animals allows the mycoplasmas to live in balance with the host system and, thus, to assure the survival of their species. To establish persistent infections and to ensure their survival despite immune response and antibiotic treatment, mycoplasma has evolved highly specialized mechanisms against adverse conditions [43], a fact that is particularly remarkable in the light of the small genomes and the limited biosynthetic capabilities of mycoplasmas. Long been recognized immune modulation and immune evasion mechanisms include molecular mimicry and antigenic variation which is comprehensively reviewed by Citti and co-workers in 2010 [44]. The present review summarizes the recent findings on novel strategies of livestock mycoplasmas to realize persistence by autoimmunity, apoptosis of different host cells, cell invasion, and biofilm formation. Finally, based on the presented findings, attempts should be made to provide approaches and strategies for future research work and, thus, to combat these bacterial infectious agents.
Dysregulation of the Immune System
Studies using molecular high-throughput technologies confirmed that Mycoplasma infections are accompanied by massive changes in the gene expression profiles of the host. Whole blood transcriptome profiling studies of M. suis-infected pigs and M. mycoides ssp. mycoides-infected cattle revealed a downregulation of the gene expression leading to a general immune suppression [45, 46]. It must be considered that this global approach reflects the sum of all local and systemic inflammatory and immune relevant host responses during the acute phase of infection. Detailed analysis of the immune response and underlying pathways either in organs, epithelial cells, or different immune cell subpopulations in vivo as well as in vitro revealed a more discriminating picture of the interference of the immune system due to Mycoplasma infections. Both immune stimulation and immune suppression were reported indicating a complex and dynamic interplay between activation and inhibition, depending on the phase of infection, the host’s immune status, the cell types or subset of peripheral blood mononuclear cells (PBMCs), and the virulence of the pathogen [47•, 48,49,50,51]. Ex vivo and in vitro analyses of tracheal epithelial cells after M. gallisepticum infection delivered a macrophage activation and upregulation of several inflammatory cytokines including IL-1β, IL-6, IL-8, IL-12p40, CCL-20, and NOS-2 [52, 53]. Moreover, M. hyopneumoniae and M. bovis were shown to stimulate the immune response through macrophages by elevating the release of pro-inflammatory cytokines such as IL-2, IL-6, and IL-1β [47•, 50, 51]. Other studies revealed a general downregulation of innate immune response-related genes in mammary lymph nodes in M. bovis-induced mastitis or an immune suppression through a significant reduction of PBMC proliferation as well as a shift of the cytokine profile from pro-inflammatory to anti-inflammatory [48,49,50]. Furthermore, M. gallisepticum induces a decrease in the expression of inflammatory cytokines such as TNFα, IL-1β, and IL-6 in infected embryonic chicken fibroblast and lung cells [54]. Decreased levels of the pro-inflammatory cytokines, e.g., TNFα and IFNγ, with concomitant elevation of anti-inflammatory cytokines like IL-10 were also reported in M. bovis-infected cattle and monocyte cultures [49, 55••]. However, the effect of M. bovis on the cells depends on the corresponding PBMC subpopulation since the expression of IFNγ was upregulated in the different types of T cells and NK cells and downregulated in monocytes, dendritic cells, and B cells [50].
Several pathogenic Mycoplasma species such as M. hyopneumoniae, M. pneumoniae, and M. ovipneumoniae are capable to evade the phagocytic uptake by host macrophages representing the major component of the innate immunity [56, 57, 58••]. Recently, a detailed look on the gene expression profile of M. hyopneumoniae-infected porcine alveolar macrophages expectedly showed a very complex and dynamic process involving massive alterations in the expression profiles mainly of the inflammatory and innate immune response, apoptosis, signal transduction, and cell adhesion [59]. Interestingly, phagocytic uptake of M. hyopneumoniae was not enhanced by convalescent antibodies indicating a possible opsonization prevention mechanism in M. hyopneumoniae. Indeed, an IgG capture and cleavage system was described in M. mycoides subspecies capri which may inhibit IgG-mediated immune defense including opsonization [60•]. This two-protein system MIB-MIP consists of an Ig-binding protein (MIB) and an Ig serine protease (MIP), which synergistically cleave the IgGs, thus enabling the evasion of humoral effector functions (e.g., complement activation, opsonization). Homologs of the MIB-MIP system were also identified in the majority of pathogenic livestock Mycoplasma species including M. hyopneumoniae, M. gallisepticum, M. bovis, and M. suis [60•].
Autoimmunity
Autoimmunity is a further immune-related mechanism that is used by mycoplasmas to manipulate the host immune system leading to evasion of a protective immune response. Thereby, autoreactive processes allow the pathogen to mask the pathogen-specific immune response. Cold reactive IgM autoantibodies (cold agglutinins) produced 1 to 2 weeks after infection are well recognized in M. pneumoniae and M. suis infections [1, 61]. The target structures of cold agglutinins are not fully elucidated, but it is assumed that cold agglutinins are directed against altered antigens or carbohydrate I antigen on the RBC surface [25, 61]. During M. suis infections, cold agglutinins contribute to the development of hemolytic anemia but also RBC agglutination at low temperatures leading to a blockage of the capillaries in the terminal vascular bed, e.g., at the edge of the ear, and thus to typical aural cyanosis [1, 62, 63].
In addition, autoantibodies of the IgG class (warm-reactive autoantibodies) were induced during M. suis infections which target the ß-actin of RBCs. B cell clones specific for cytoskeletal actin or band 3 are known as physiological components, and it was suggested that M. suis leads to a massive and unspecific B cell proliferation of these B cell clones. Other theories include the alteration of the RBC due to the adhesion of M. suis resulting in the exposure of so far hidden cytoskeletal antigens or molecular mimicry due to autologous epitopes between the adhesion protein MSG1 and ß-actin [64].
Programmed Cell Death (Apoptosis, Eryptosis) as Modulating Mechanism
Modulating programmed cell death pathways is another mechanism used by mycoplasmas to manipulate the immune system during the pathogenesis in farm animals [65,66,67,68,69]. Apoptosis enhancement of immune cells could negatively regulate the host’s defense system. On the other hand, downregulation of apoptosis is a crucial factor to achieve persistence and ensure bacterial survival. For instance, triggering apoptosis in thymocytes was described for M. gallisepticum, thus interfering profoundly both with the development and the effectiveness of the adaptive immune response [66]. In addition, M. hyopneumoniae is reported to significantly provoke apoptosis in PBMCs (i.e., lymphocytes and monocytes) as well as in alveolar macrophages, the essential cell type for local innate immunity in the lungs [70]. Modulation of apoptosis was also found for M. bovis for PBMC and RBCs [50]. Interestingly, in vitro studies determined both apoptosis induction and delay in PBMCs suggesting that M. bovis is capable to regulate the cellular apoptosis machinery depending on the infection phase [49,50,51]. Programmed cell death of RBCs (so-called eryptosis) was also found during infection with the hemotrophic M. suis [65].
The severity of the clinical disease outcome could be proportional to the degree of apoptosis induced by mycoplasmas [65, 71]. Moreover, host- and strain-specific differences in apoptosis of alveolar macrophages were also found for M. bovis. For example, M. bovis isolates from bison showed less modulation of apoptosis in vitro than M. bovis isolates from cattle [72]. Felder and co-workers described similar observations in connection with eryptosis in M. suis infections in pigs. In these investigations, a clear correlation between the eryptosis ratio and the virulence of the M. suis isolates in connection with the severity of the course of the infection was found [65].
Despite these reports, the molecular mechanisms responsible for apoptosis modulation are not fully elucidated. Beyond the induction of oxidative stress, mitochondrial dysfunctions or membrane changes due to direct interactions of the mycoplasmas with the host cell membrane are discussed as the cause of apoptosis [66, 71]. Thereby, lipid-associated membrane proteins function as an apoptosis inducer in M. hyopneumoniae infections in vitro through p38 MAPK and Bax/Bcl-2 signaling pathways as well as caspase activation [71, 73]. Moreover, the involvement of the calcium homeostasis, as well as ER stress, was observed in the apoptosis events induced in infected tracheal cells [74]. In M. gallisepticum, the GroEL protein (heat shock protein 60) was detected as an inducer of apoptosis in PBMCs. The interaction of the GroEL with annexin A2 obviously plays a key role in this process [69].
In M. bovis infections, this apoptosis process is associated with an increased expression of PD-1 (programmed cell death protein 1) and thus the involvement of the so-called PD-1/PD-L1 pathway. Prostaglandin E2 (PGE2) plays a role as an inducer of the PD-L1 expression and could thus be involved in immunosuppression during an M. bovis infection [55••, 75].
Cell Invasion
Previously, mycoplasmas were considered to be extracellular bacteria that attach to the surface of epithelial cells of the respiratory tract, the joints, and the mammary glands (M. bovis, M. hyopneumoniae, M. gallisepticum) or to RBCs (hemotrophic Mycoplasma species). However, by now, it is more and more recognized that several mycoplasmas can invade and persist within host cells. Mycoplasma penetrans originally isolated from the urogenital tract of HIV patients was the first described cell invader [76]. During the last few years, exhaustive research using modern imaging technologies proved the capability to enter non-phagocytic and/or phagocytic cells also for several livestock-infecting Mycoplasma species.
An intracellular location of M. bovis was shown in situ in degenerated macrophages in lung tissue of infected animals and in inflammatory cells, hepatocytes, renal tubule epithelial cells, and facial nerve bundles of necrotic tissue samples [77, 78]. In addition, the ability of M. bovis to invade bovine mononuclear blood cells (PBMC), embryonic calf turbinate cells, embryonic bovine tracheal cells, and epithelial cells from bovine kidney and the mammary gland was demonstrated in several studies in vitro [34, 50, 79, 80]. Recently, in M. hyopneumoniae which was considered as a strict extracellular pathogen for a long time, the capacity to enter porcine epithelial cells in vitro was shown [81••]. Moreover, invasiveness is demonstrated in further livestock mycoplasmas, i.e., M. gallisepticum in RBCs, HeLa cells, and chicken embryo fibroblasts; hemotrophic M. suis in RBCs; and M. agalactiae in epithelial cells and fibroblasts [82,83,84,85].
Several advantages such as protection from the host’s immune defense, resistance against antibiotic therapy, and the supply with sufficient nutrients are associated with the intracellular lifestyle [82, 84]. Thus, the intracellular niche offers a protected environment to establish a chronic persistent infection that allows the egress and propagation upon the return to favorable extracellular conditions in the host. Moreover, internalization and, therefore, cellular masking of the pathogen may also contribute to a better translocation through cell barriers and/or effective dissemination by the bloodstream. Actually, M. hyopneumoniae could be isolated outside the respiratory tract in pericardial and synovial joint fluids in slaughter pigs with fibrinous pericarditis, and M. gallisepticum was found in various inner organs (e.g., kidney, liver, brain) of chicken experimentally infected via aerosol [81••, 86, 87]. It seems clear that mycoplasmas can overcome typical body barriers like the blood-brain barrier (BBB) due to their intracellular lifestyle [83, 88•]. For instance, various Mycoplasma species normally found as colonizers in organ systems, e.g., the udder or respiratory tract, were also detected in the brain of the infected animals even associated with encephalopathies and ataxias; e.g., M. agalactiae was found in large amounts in the brain associated with non-purulent encephalitis as well as ataxia in young animals [89]. Moreover, M. gallisepticum and M. synoviae were also isolated from the brain of animals with meningeal vasculitis and encephalitis [88•]. So, pathogenic mycoplasmas may pass the BBB and cause neuropathological effects. How they cross this barrier is currently unknown. The involvement of toxins (e.g., CARDS toxins) that could lead to an increase in BBB permeability through inflammatory reactions is discussed [88•, 90].
Invasiveness may also be associated with an increase in virulence, as described for some livestock Mycoplasma species. For example, cell-invasive M. gallisepticum strain R_low was shown to be more virulent than the marginally invasive strain R_high [91], and the RBC invasive M. suis strain 08/07 also exhibited a considerably enhanced virulence in experimentally infected pigs [82]. Comparative analyses of the genome sequences revealed no correlates for the differences in virulence between invasive and noninvasive strains. In addition, no hints for classically known bacterial invasins were found in the Mycoplasma genomes. Although invasiveness seems to be a very important pathogenesis determinant in livestock Mycoplasma infections, our knowledge on the underlying molecular mechanisms are rather fragmentary.
Initially, adhesion is the first essential step toward internalization. Obviously, the interaction of bacterial proteins and extracellular matrix proteins such as fibrinogen plays an important role as an initial trigger for cell entry. Binding of M. gallisepticum to plasminogen and fibronectin and of M. hyopneumoniae to fibronectin was described by several research groups [81••, 91, 92]. Various fibronectin-binding proteins were also identified for M. bovis [93,94,95,96]. It is supposed that binding to fibronectin acts as a mediating bridge between the pathogen and host cell receptors of the integrin family initiating the uptake in non-phagocytic cells. Recently, it was shown by Raymond and co-workers that the interaction of M. hyopneumoniae with surface-associated fibronectin mediates the association with the integrin β1 on the surface of epithelial cells, thus initiating signaling events and stimulating the cellular uptake [81••]. Binding to cell surfaces via plasminogen, on the other side, could also contribute to cell invasion via the formation of hydrogen bonds [97]. In addition, it is also supposed that extracellular β-actin could be an important receptor for M. hyopneumoniae on pig lung cells and M. suis on epithelial cells [98, 99].
Mycoplasma moonlighting proteins were shown to be involved in adhesion and extracellular matrix-binding activities which could be due to fully exploit the limited capacity of their minimal genomes. Examples for this include the α-enolase in M. bovis, M. hyopneumoniae, and M. suis; the GAPDH in M. suis; EFTu in M. hyopneumoniae; and NAD oxidase and the tRNA methyltransferase TrmFO in M. bovis [94, 96, 97, 100,101,102,103,104].
Overall, as already mentioned, there is still very little knowledge about the mechanisms and receptors that are used by livestock Mycoplasma species to invade cells and, therefore, still a great need for further research on this topic.
Biofilm and Microcolony Formation
The formation of biofilms and microcolonies represents a further mechanism of bacterial persistence. Adherent biofilms or bacteria within the biofilms are resistant to antibiotics, antibodies, and phagocytosis. Biofilms usually contain a large proportion of persister cells, which are periodically and intermittently released into the surrounding tissue and can, therefore, lead to a recurrent active infection after antibiosis or when the immune response decays [105, 106]. Besides, biofilms can also increase host tissue damage by attracting phagocytes and releasing lysosomal enzymes and reactive oxygen and nitrogen species (ROS and RNS), whereas phagocytosis is rather inefficient under these conditions [107].
Up to now, it is well known that livestock mycoplasmas are able to form biofilms on both abiotic and biotic surfaces [107, 108]. These consist of either single cells or functionally heterogeneous microcolonies, which are held together by bacterial polymeric substances (polysaccharides, lipids, proteins, and extracellular DNA) [107]. In vitro studies on the biofilm formation of M. bovis on abiotic surfaces showed that the cell adherence capacity appears to be essential since the adherence to cover glasses as the first step in the formation of biofilm in M. bovis strains was very different due to the different expression of variable surface proteins [107]. Furthermore, in the case of M. hyopneumoniae biofilm formation on abiotic surfaces, extracellular DNA release seems to be essential for biofilm formation [108].
Moreover, biofilm-forming M. bovis strains were as expected more resistant to heat and dehydration which allow them to better survive in the environment. There are different data on the antibiotic resistance of mycoplasma in biofilms. While no change in the minimum inhibitory concentrations (MIC) of fluoroquinolones and tetracyclines was found for M. bovis, there was a significant increase in the MICs for M. hyopneumoniae for quinolones, colistin, gentamicin, and oxytetracycline [107, 109].
Biofilms or biofilm-like microcolonies could also be detected in vivo in experimentally infected animals. In one study, microcolonies of M. suis were electron microscopically observed on vascular endothelial cells [99]. Raymond and co-workers ultrastructurally found similar structures on the ciliated epithelium of the respiratory tract in M. hyopneumoniae-infected pigs [108]. In both reports, there was also evidence that these biofilm-associated mycoplasmas could have morphological changes leading to a pleomorphic shape [99, 108].
Conclusions
A resume of the current research studies addressing the biology of Mycoplasma species causing economic significant diseases in farm animals indicates that the induction of persistent infections is the central and critical attempt of the highly adapted and host-specific Mycoplasma species to principally survive.
Therefore, analysis of the molecular pathways of the host-pathogen balance leading to persistence is one of the most important topics in mycoplasmal research. Next-generation high-throughput technologies (genomics, proteomics, transcriptomics, metabolomics) are very valuable tools to elucidate the pathobiology and host response in mycoplasma-associated livestock diseases caused by mycoplasmas in the future. Extended insights on persistence mechanisms will be the basis to develop much needed novel vaccine strategies and therapy options leading to reduced usage of antibiotics in farm animals.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Hoelzle LE, Zeder M, Felder KM, Hoelzle K. Pathobiology of Mycoplasma suis. Vet J. 2014;202(1):20–5. https://doi.org/10.1016/j.tvjl.2014.07.023.
Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev. 1998;62(4):1094–156.
Perez-Casal J, Prysliak T, Maina T, Suleman M, Jimbo S. Status of the development of a vaccine against Mycoplasma bovis. Vaccine. 2017;35(22):2902–7. https://doi.org/10.1016/j.vaccine.2017.03.095.
Citti C, Blanchard A. Mycoplasmas and their host: emerging and re-emerging minimal pathogens. Trends Microbiol. 2013;21(4):196–203. https://doi.org/10.1016/j.tim.2013.01.003.
Gautier-Bouchardon AV. Antimicrobial resistance in Mycoplasma spp. Microbiol Spectr. 2018;6(4). https://doi.org/10.1128/microbiolspec.ARBA-0030-2018.
Maes D, Sibila M, Kuhnert P, Segales J, Haesebrouck F, Pieters M. Update on mycoplasma hyopneumoniae infections in pigs: knowledge gaps for improved disease control. Transbound Emerg Dis. 2018;65(Suppl 1):110–24. https://doi.org/10.1111/tbed.12677.
Martinson B, Minion FC, Jordan D. Development and optimization of a cell-associated challenge model for Mycoplasma hyorhinis in 7-week-old cesarean-derived, colostrum-deprived pigs. Can J Vet Res. 2018;82(1):12–23.
Felice V, Lupini C, Mescolini G, Silveira F, Guerrini A, Catelli E, et al. Molecular detection and characterization of Mycoplasma gallisepticum and Mycoplasma synoviae strains in backyard poultry in Italy. Poult Sci. 2020;99(2):719–24. https://doi.org/10.1016/j.psj.2019.12.020.
Jaÿ M, Tardy F. Contagious agalactia in sheep and goats: current perspectives. Vet Med (Auckl). 2019;10:229–47. https://doi.org/10.2147/vmrr.S201847.
Roos LR, Surendran Nair M, Rendahl AK, Pieters M. Mycoplasma hyorhinis and Mycoplasma hyosynoviae dual detection patterns in dams and piglets. PLoS One. 2019;14(1):e0209975. https://doi.org/10.1371/journal.pone.0209975.
Thiaucourt F, Lorenzon S, David A, Breard A. Phylogeny of the Mycoplasma mycoides cluster as shown by sequencing of a putative membrane protein gene. Vet Microbiol. 2000;72(3–4):251–68. https://doi.org/10.1016/s0378-1135(99)00204-7.
Maunsell FP, Woolums AR, Francoz D, Rosenbusch RF, Step DL, Wilson DJ, et al. Mycoplasma bovis infections in cattle. J Vet Intern Med. 2011;25(4):772–83. https://doi.org/10.1111/j.1939-1676.2011.0750.x.
Ade J, Niethammer F, Schade B, Schilling T, Hoelzle K, Hoelzle LE. Quantitative analysis of Mycoplasma wenyonii and “Candidatus Mycoplasma haemobos” infections in cattle using novel gapN-based realtime PCR assays. Vet Microbiol. 2018;220:1–6. https://doi.org/10.1016/j.vetmic.2018.04.028.
Nouvel LX, Hygonenq MC, Catays G, Martinelli E, Le Page P, Collin É, et al. First detection of Mycoplasma wenyonii in France: identification, evaluation of the clinical impact and development of a new specific detection assay. Comp Immunol Microbiol Infect Dis. 2019;63:148–53. https://doi.org/10.1016/j.cimid.2019.01.010.
Hoelzle K, Winkler M, Kramer MM, Wittenbrink MM, Dieckmann SM, Hoelzle LE. Detection of Candidatus Mycoplasma haemobos in cattle with anaemia. Vet J. 2011;187(3):408–10. https://doi.org/10.1016/j.tvjl.2010.01.016.
Kumar A, Rahal A, Chakraborty S, Verma AK, Dhama K. Mycoplasma agalactiae, an etiological agent of contagious agalactia in small ruminants: a review. Vet Med Int. 2014;2014:286752. https://doi.org/10.1155/2014/286752.
Iqbal Yatoo M, Raffiq Parray O, Tauseef Bashir S, Ahmed Bhat R, Gopalakrishnan A, Karthik K, et al. Contagious caprine pleuropneumonia - a comprehensive review. Vet Q. 2019;39(1):1–25. https://doi.org/10.1080/01652176.2019.1580826.
Neimark H, Hoff B, Ganter M. Mycoplasma ovis comb. nov. (formerly Eperythrozoon ovis), an epierythrocytic agent of haemolytic anaemia in sheep and goats. Int J Syst Evol Microbiol. 2004;54(Pt 2):365–71. https://doi.org/10.1099/ijs.0.02858-0.
Suzuki J, Sasaoka F, Fujihara M, Watanabe Y, Tasaki T, Oda S, et al. Molecular identification of `Candidatus Mycoplasma haemovis' in sheep with hemolytic anemia. J Vet Med Sci. 2011;73(8):1113–5. https://doi.org/10.1292/jvms.11-0113.
Garcia-Morante B, Segalés J, Fraile L, Pérez de Rozas A, Maiti H, Coll T, et al. Assessment of Mycoplasma hyopneumoniae-induced pneumonia using different lung lesion scoring systems: a comparative review. J Comp Pathol. 2016;154(2–3):125–34. https://doi.org/10.1016/j.jcpa.2015.11.003.
Clavijo MJ, Davies P, Morrison R, Bruner L, Olson S, Rosey E, et al. Temporal patterns of colonization and infection with Mycoplasma hyorhinis in two swine production systems in the USA. Vet Microbiol. 2019;234:110–8. https://doi.org/10.1016/j.vetmic.2019.05.021.
Clavijo MJ, Murray D, Oliveira S, Rovira A. Infection dynamics of Mycoplasma hyorhinis in three commercial pig populations. Vet Rec. 2017;181(3):68. https://doi.org/10.1136/vr.104064.
Resende TP, Pieters M, Vannucci FA. Swine conjunctivitis outbreaks associated with Mycoplasma hyorhinis. J Vet Diagn Investig. 2019;31(5):766–9. https://doi.org/10.1177/1040638719865767.
Pillman D, Surendran Nair M, Schwartz J, Pieters M. Detection of Mycoplasma hyorhinis and Mycoplasma hyosynoviae in oral fluids and correlation with pig lameness scores. Vet Microbiol. 2019;239:108448. https://doi.org/10.1016/j.vetmic.2019.108448.
Hoelzle LE. Haemotrophic mycoplasmas: recent advances in Mycoplasma suis. Vet Microbiol. 2008;130(3–4):215–26. https://doi.org/10.1016/j.vetmic.2007.12.023.
Messick JB. Hemotrophic mycoplasmas (hemoplasmas): a review and new insights into pathogenic potential. Vet Clin Pathol. 2004;33(1):2–13. https://doi.org/10.1111/j.1939-165x.2004.tb00342.x.
do Nascimento NC, Dos Santos AP, Chu Y, Guimaraes AM, Pagliaro A, Messick JB. Genome sequence of Mycoplasma parvum (formerly Eperythrozoon parvum), a diminutive hemoplasma of the pig. Genome Announc. 2013;1(6). https://doi.org/10.1128/genomeA.00986-13.
Fu Y, Shi T, Xu L, Wei W, Lu F, Zhang X, et al. Identification of a novel Hemoplasma species from pigs in Zhejiang province, China. J Vet Med Sci. 2017;79(5):864–70. https://doi.org/10.1292/jvms.16-0545.
Seo MG, Kwon OD, Kwak D. Prevalence and phylogenetic analysis of hemoplasma species in domestic pigs in Korea. Parasit Vectors. 2019;12(1):378–7. https://doi.org/10.1186/s13071-019-3638-x.
Stadler J, Ade J, Ritzmann M, Hoelzle K, Hoelzle LE. Detection of a novel haemoplasma species in fattening pigs with skin alterations, fever and anaemia. Vet Rec. 2020. https://doi.org/10.1136/vr.105721.
Kleven SH. Mycoplasmas in the etiology of multifactorial respiratory disease. Poult Sci. 1998;77(8):1146–9. https://doi.org/10.1093/ps/77.8.1146.
Landman WJ. Is Mycoplasma synoviae outrunning Mycoplasma gallisepticum? A viewpoint from the Netherlands. Avian Pathol. 2014;43(1):2–8. https://doi.org/10.1080/03079457.2014.881049.
Levisohn S, Kleven SH. Avian mycoplasmosis (Mycoplasma gallisepticum). Rev Sci Tech. 2000;19(2):425–42.
Burki S, Gaschen V, Stoffel MH, Stojiljkovic A, Frey J, Kuehni-Boghenbor K, et al. Invasion and persistence of Mycoplasma bovis in embryonic calf turbinate cells. Vet Res. 2015;46:53. https://doi.org/10.1186/s13567-015-0194-z.
Fourour S, Tocqueville V, Paboeuf F, Lediguerher G, Morin N, Kempf I, et al. Pathogenicity study of Mycoplasma hyorhinis and M. flocculare in specific-pathogen-free pigs pre-infected with M. hyopneumoniae. Vet Microbiol. 2019;232:50–7. https://doi.org/10.1016/j.vetmic.2019.04.010.
Neimark H, Johansson KE, Rikihisa Y, Tully JG. Proposal to transfer some members of the genera Haemobartonella and Eperythrozoon to the genus Mycoplasma with descriptions of 'Candidatus Mycoplasma haemofelis', 'Candidatus Mycoplasma haemomuris', 'Candidatus Mycoplasma haemosuis' and 'Candidatus Mycoplasma wenyonii'. Int J Syst Evol Microbiol. 2001;51(Pt 3):891–9. https://doi.org/10.1099/00207713-51-3-891.
Hornok S, Hajtos I, Meli ML, Farkas I, Gonczi E, Meili T, et al. First molecular identification of Mycoplasma ovis and 'Candidatus M. haemoovis' from goat, with lack of haemoplasma PCR-positivity in lice. Acta Vet Hung. 2012;60(3):355–60. https://doi.org/10.1556/AVet.2012.030.
Machado CAL, Vidotto O, Conrado FO, Santos NJR, Valente JDM, Barbosa IC, et al. Mycoplasma ovis infection in goat farms from northeastern Brazil. Comp Immunol Microbiol Infect Dis. 2017;55:1–5. https://doi.org/10.1016/j.cimid.2017.08.004.
Ritzmann M, Grimm J, Heinritzi K, Hoelzle K, Hoelzle LE. Prevalence of Mycoplasma suis in slaughter pigs, with correlation of PCR results to hematological findings. Vet Microbiol. 2009;133(1–2):84–91. https://doi.org/10.1016/j.vetmic.2008.06.015.
Dorr PM, Baker RB, Almond GW, Wayne SR, Gebreyes WA. Epidemiologic assessment of porcine circovirus type 2 coinfection with other pathogens in swine. J Am Vet Med Assoc. 2007;230(2):244–50. https://doi.org/10.2460/javma.230.2.244.
Shahriar FM, Clark EG, Janzen E, West K, Wobeser G. Coinfection with bovine viral diarrhea virus and Mycoplasma bovis in feedlot cattle with chronic pneumonia. Can Vet J. 2002;43(11):863–8.
Baseman JB, Tully JG. Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety. Emerg Infect Dis. 1997;3(1):21–32. https://doi.org/10.3201/eid0301.970103.
Burki S, Frey J, Pilo P. Virulence, persistence and dissemination of Mycoplasma bovis. Vet Microbiol. 2015;179(1–2):15–22. https://doi.org/10.1016/j.vetmic.2015.02.024.
Citti C, Nouvel LX, Baranowski E. Phase and antigenic variation in mycoplasmas. Future Microbiol. 2010;5(7):1073–85. https://doi.org/10.2217/fmb.10.71.
do Nascimento NC, AMS G, Dos Santos AP, Chu Y, Marques LM, Messick JB. RNA-Seq based transcriptome of whole blood from immunocompetent pigs (Sus scrofa) experimentally infected with Mycoplasma suis strain Illinois. Vet Res. 2018;49(1):49. https://doi.org/10.1186/s13567-018-0546-6.
Rodrigues V, Holzmuller P, Puech C, Wesonga H, Thiaucourt F, Manso-Silvan L. Whole blood transcriptome analysis of mycoplasma mycoides subsp. mycoides-infected cattle confirms immunosuppression but does not reflect local inflammation. PLoS One. 2015;10(10):e0139678. https://doi.org/10.1371/journal.pone.0139678.
• Fourour S, Marois-Crehan C, Martelet L, Fablet C, Kempf I, Gottschalk M, et al. Intra-species and inter-species differences in cytokine production by porcine antigen-presenting cells stimulated by Mycoplasma hyopneumoniae, M. hyorhinis, and M. flocculare. Pathogens. 2019;8(1). https://doi.org/10.3390/pathogens8010034This paper elucidates the species-specific character of the immune modulation by mycoplasmas.
Gondaira S, Higuchi H, Iwano H, Nishi K, Nebu T, Nakajima K, et al. Innate immune response of bovine mammary epithelial cells to Mycoplasma bovis. J Vet Sci. 2018;19(1):79–87. https://doi.org/10.4142/jvs.2018.19.1.79.
Mulongo M, Prysliak T, Scruten E, Napper S, Perez-Casal J. In vitro infection of bovine monocytes with Mycoplasma bovis delays apoptosis and suppresses production of gamma interferon and tumor necrosis factor alpha but not interleukin-10. Infect Immun. 2014;82(1):62–71. https://doi.org/10.1128/iai.00961-13.
van der Merwe J, Prysliak T, Perez-Casal J. Invasion of bovine peripheral blood mononuclear cells and erythrocytes by Mycoplasma bovis. Infect Immun. 2010;78(11):4570–8. https://doi.org/10.1128/iai.00707-10.
Vanden Bush TJ, Rosenbusch RF. Mycoplasma bovis induces apoptosis of bovine lymphocytes. FEMS Immunol Med Microbiol. 2002;32(2):97–103. https://doi.org/10.1111/j.1574-695X.2002.tb00540.x.
Majumder S, Silbart LK. Interaction of Mycoplasma gallisepticum with chicken tracheal epithelial cells contributes to macrophage chemotaxis and activation. Infect Immun. 2016;84(1):266–74. https://doi.org/10.1128/iai.01113-15.
Majumder S, Zappulla F, Silbart LK. Mycoplasma gallisepticum lipid associated membrane proteins up-regulate inflammatory genes in chicken tracheal epithelial cells via TLR-2 ligation through an NF-kappaB dependent pathway. PLoS One. 2014;9(11):e112796. https://doi.org/10.1371/journal.pone.0112796.
Zhao Y, Zhang K, Zou M, Sun Y, Peng X. gga-miR-451 negatively regulates mycoplasma gallisepticum (HS Strain)-induced inflammatory cytokine production via targeting YWHAZ. Int J Mol Sci. 2018;19(4). https://doi.org/10.3390/ijms19041191.
•• Goto S, Konnai S, Okagawa T, Nishimori A, Maekawa N, Gondaira S, et al. Increase of cells expressing PD-1 and PD-L1 and enhancement of IFN-gamma production via PD-1/PD-L1 blockade in bovine mycoplasmosis. Immun Inflamm Dis. 2017;5(3):355–63. https://doi.org/10.1002/iid3.173This paper gives detailed information on molecular apoptosis mechanisms.
Al-Kaissi A, Alley MR. Electron microscopic studies of the interaction between ovine alveolar macrophages and Mycoplasma ovipneumoniae in vitro. Vet Microbiol. 1983;8(6):571–84. https://doi.org/10.1016/0378-1135(83)90006-8.
Busolo F, Tonellato L, Scremin L, Tonin E, Bertoloni G, Franceschi C. Phagocytosis of Mycoplasma pneumoniae and Acholeplasma laidlawii measured as inhibition of [3H]uridine uptake by macrophages. J Immunol Methods. 1986;90(2):235–40. https://doi.org/10.1016/0022-1759(86)90080-3.
•• Deeney AS, Maglennon GA, Chapat L, Crussard S, Jolivet E, Rycroft AN. Mycoplasma hyopneumoniae evades phagocytic uptake by porcine alveolar macrophages in vitro. Vet Res. 2019;50(1):51. https://doi.org/10.1186/s13567-019-0667-6This paper highlights the immune evasion of mycoplasmas via inhibition of phagocytosis.
Bin L, Luping D, Bing S, Zhengyu Y, Maojun L, Zhixin F, et al. Transcription analysis of the porcine alveolar macrophage response to Mycoplasma hyopneumoniae. PLoS One. 2014;9(8):e101968. https://doi.org/10.1371/journal.pone.0101968.
• Arfi Y, Minder L, Di Primo C, Le Roy A, Ebel C, Coquet L, et al. MIB-MIP is a mycoplasma system that captures and cleaves immunoglobulin G. Proc Natl Acad Sci U S A. 2016;113(19):5406–11. https://doi.org/10.1073/pnas.1600546113Description of the molecular mechanisms leading to immune globulin cleavage.
Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17(4):697–728, table of contents. https://doi.org/10.1128/cmr.17.4.697-728.2004.
Jungling A, Erhard MH, Heinritzi K, Losch U. Significance and course of a cold agglutinin in Eperythrozoon suis infection of swine. Berl Munch Tierarztl Wochenschr. 1994;107(8):271–5.
Schmidt P, Kaspers B, Jungling A, Heinritzi K, Losch U. Isolation of cold agglutinins in Eperythrozoon suis-infected pigs. Vet Immunol Immunopathol. 1992;31(1–2):195–201. https://doi.org/10.1016/0165-2427(92)90097-a.
Felder KM, Hoelzle K, Heinritzi K, Ritzmann M, Hoelzle LE. Antibodies to actin in autoimmune haemolytic anaemia. BMC Vet Res. 2010;6:18. https://doi.org/10.1186/1746-6148-6-18.
Felder KM, Hoelzle K, Ritzmann M, Kilchling T, Schiele D, Heinritzi K, et al. Hemotrophic mycoplasmas induce programmed cell death in red blood cells. Cell Physiol Biochem. 2011;27(5):557–64. https://doi.org/10.1159/000329957.
Ishfaq M, Chen C, Bao J, Zhang W, Wu Z, Wang J, et al. Baicalin ameliorates oxidative stress and apoptosis by restoring mitochondrial dynamics in the spleen of chickens via the opposite modulation of NF-kappaB and Nrf2/HO-1 signaling pathway during Mycoplasma gallisepticum infection. Poult Sci. 2019;98(12):6296–310. https://doi.org/10.3382/ps/pez406.
Li J, Qiao Z, Hu W, Zhang W, Shah SWA, Ishfaq M. Baicalin mitigated Mycoplasma gallisepticum-induced structural damage and attenuated oxidative stress and apoptosis in chicken thymus through the Nrf2/HO-1 defence pathway. Vet Res. 2019;50(1):83. https://doi.org/10.1186/s13567-019-0703-6.
Maunsell FP, Chase C. Mycoplasma bovis: interactions with the immune system and failure to generate an effective immune response. Vet Clin North Am Food Anim Pract. 2019;35(3):471–83. https://doi.org/10.1016/j.cvfa.2019.08.003.
Yu Y, Zhang L, Chen Y, Li Y, Wang Z, Li G, et al. GroEL protein (heat shock protein 60) of Mycoplasma gallisepticum induces apoptosis in host cells by interacting with annexin A2. Infect Immun. 2019;87(9). https://doi.org/10.1128/iai.00248-19.
Li P, Zhang Y, Li X, Zhou W, Li X, Jiang F, et al. Mycoplasma hyopneumoniae Mhp597 is a cytotoxicity, inflammation and immunosuppression associated nuclease. Vet Microbiol. 2019;235:53–62. https://doi.org/10.1016/j.vetmic.2019.05.011.
Liu W, Zhou D, Yuan F, Liu Z, Duan Z, Yang K, et al. Surface proteins mhp390 (P68) contributes to cilium adherence and mediates inflammation and apoptosis in Mycoplasma hyopneumoniae. Microb Pathog. 2019;126:92–100. https://doi.org/10.1016/j.micpath.2018.10.035.
Suleman M, Prysliak T, Clarke K, Burrage P, Windeyer C, Perez-Casal J. Mycoplasma bovis isolates recovered from cattle and bison (Bison bison) show differential in vitro effects on PBMC proliferation, alveolar macrophage apoptosis and invasion of epithelial and immune cells. Vet Microbiol. 2016;186:28–36. https://doi.org/10.1016/j.vetmic.2016.02.016.
Bai F, Ni B, Liu M, Feng Z, Xiong Q, Shao G. Mycoplasma hyopneumoniae-derived lipid-associated membrane proteins induce inflammation and apoptosis in porcine peripheral blood mononuclear cells in vitro. Vet Microbiol. 2015;175(1):58–67. https://doi.org/10.1016/j.vetmic.2014.11.013.
Leal Zimmer FMA, Moura H, Barr JR, Ferreira HB. Intracellular changes of a swine tracheal cell line infected with a Mycoplasma hyopneumoniae pathogenic strain. Microb Pathog. 2019;137:103717. https://doi.org/10.1016/j.micpath.2019.103717.
Goto S, Konnai S, Hirano Y, Kohara J, Okagawa T, Maekawa N, et al. Upregulation of PD-L1 expression by prostaglandin E2 and the enhancement of IFN-gamma by anti-PD-L1 antibody combined with a COX-2 inhibitor in Mycoplasma bovis infection. Front Vet Sci. 2020;7:12. https://doi.org/10.3389/fvets.2020.00012.
Lo SC, Hayes MM, Tully JG, Wang RY, Kotani H, Pierce PF, et al. Mycoplasma penetrans sp. nov., from the urogenital tract of patients with AIDS. Int J Syst Bacteriol. 1992;42(3):357–64. https://doi.org/10.1099/00207713-42-3-357.
Kleinschmidt S, Spergser J, Rosengarten R, Hewicker-Trautwein M. Long-term survival of Mycoplasma bovis in necrotic lesions and in phagocytic cells as demonstrated by transmission and immunogold electron microscopy in lung tissue from experimentally infected calves. Vet Microbiol. 2013;162(2–4):949–53. https://doi.org/10.1016/j.vetmic.2012.11.039.
Maeda T, Shibahara T, Kimura K, Wada Y, Sato K, Imada Y, et al. Mycoplasma bovis-associated suppurative otitis media and pneumonia in bull calves. J Comp Pathol. 2003;129(2–3):100–10. https://doi.org/10.1016/s0021-9975(03)00009-4.
Jimbo S, Suleman M, Maina T, Prysliak T, Mulongo M, Perez-Casal J. Effect of Mycoplasma bovis on bovine neutrophils. Vet Immunol Immunopathol. 2017;188:27–33. https://doi.org/10.1016/j.vetimm.2017.04.011.
Josi C, Burki S, Stojiljkovic A, Wellnitz O, Stoffel MH, Pilo P. Bovine epithelial in vitro infection models for Mycoplasma bovis. Front Cell Infect Microbiol. 2018;8:329. https://doi.org/10.3389/fcimb.2018.00329.
•• Raymond BBA, Turnbull L, Jenkins C, Madhkoor R, Schleicher I, Uphoff CC, et al. Mycoplasma hyopneumoniae resides intracellularly within porcine epithelial cells. Sci Rep. 2018;8(1):17697. https://doi.org/10.1038/s41598-018-36054-3First proof of intracellular lifestyle of M. hyopneumoniae.
Groebel K, Hoelzle K, Wittenbrink MM, Ziegler U, Hoelzle LE. Mycoplasma suis invades porcine erythrocytes. Infect Immun. 2009;77(2):576–84. https://doi.org/10.1128/iai.00773-08.
Hegde S, Hegde S, Spergser J, Brunthaler R, Rosengarten R, Chopra-Dewasthaly R. In vitro and in vivo cell invasion and systemic spreading of Mycoplasma agalactiae in the sheep infection model. Int J Med Microbiol. 2014;304(8):1024–31. https://doi.org/10.1016/j.ijmm.2014.07.011.
Vogl G, Plaickner A, Szathmary S, Stipkovits L, Rosengarten R, Szostak MP. Mycoplasma gallisepticum invades chicken erythrocytes during infection. Infect Immun. 2008;76(1):71–7. https://doi.org/10.1128/iai.00871-07.
Winner F, Rosengarten R, Citti C. In vitro cell invasion of Mycoplasma gallisepticum. Infect Immun. 2000;68(7):4238–44. https://doi.org/10.1128/iai.68.7.4238-4244.2000.
Buttenschøn J, Friis NF, Aalbaek B, Jensen TK, Iburg T, Mousing J. Microbiology and pathology of fibrinous pericarditis in Danish slaughter pigs. Zentralbl Veterinarmed A. 1997;44(5):271–80. https://doi.org/10.1111/j.1439-0442.1997.tb01111.x.
Much P, Winner F, Stipkovits L, Rosengarten R, Citti C. Mycoplasma gallisepticum: influence of cell invasiveness on the outcome of experimental infection in chickens. FEMS Immunol Med Microbiol. 2002;34(3):181–6. https://doi.org/10.1111/j.1574-695X.2002.tb00622.x.
• Rosales RS, Puleio R, Loria GR, Catania S, Nicholas RAJ. Mycoplasmas: brain invaders? Res Vet Sci. 2017;113:56–61. https://doi.org/10.1016/j.rvsc.2017.09.006This paper describes the passage of mycoplasmas through the BBB.
Gomez-Martin A, De la Fe C, Amores J, Sanchez A, Contreras A, Paterna A, et al. Anatomic location of Mycoplasma mycoides subsp. capri and Mycoplasma agalactiae in naturally infected goat male auricular carriers. Vet Microbiol. 2012;157(3–4):355–62. https://doi.org/10.1016/j.vetmic.2012.01.004.
Kannan TR, Baseman JB. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc Natl Acad Sci U S A. 2006;103(17):6724–9. https://doi.org/10.1073/pnas.0510644103.
Furnkranz U, Siebert-Gulle K, Rosengarten R, Szostak MP. Factors influencing the cell adhesion and invasion capacity of Mycoplasma gallisepticum. Acta Vet Scand. 2013;55:63. https://doi.org/10.1186/1751-0147-55-63.
Seymour LM, Jenkins C, Deutscher AT, Raymond BB, Padula MP, Tacchi JL, et al. Mhp182 (P102) binds fibronectin and contributes to the recruitment of plasmin(ogen) to the Mycoplasma hyopneumoniae cell surface. Cell Microbiol. 2012;14(1):81–94. https://doi.org/10.1111/j.1462-5822.2011.01702.x.
Chen X, Huang J, Zhu H, Guo Y, Khan FA, Menghwar H, et al. P27 (MBOV_RS03440) is a novel fibronectin binding adhesin of Mycoplasma bovis. Int J Med Microbiol. 2018;308(7):848–57. https://doi.org/10.1016/j.ijmm.2018.07.006.
Guo Y, Zhu H, Wang J, Huang J, Khan FA, Zhang J, et al. TrmFO, a fibronectin-binding adhesin of Mycoplasma bovis. Int J Mol Sci. 2017;18(8). https://doi.org/10.3390/ijms18081732.
Huang J, Zhu H, Wang J, Guo Y, Zhi Y, Wei H, et al. Fructose-1,6-bisphosphate aldolase is involved in Mycoplasma bovis colonization as a fibronectin-binding adhesin. Res Vet Sci. 2019;124:70–8. https://doi.org/10.1016/j.rvsc.2019.02.010.
Zhao G, Zhang H, Chen X, Zhu X, Guo Y, He C, et al. Mycoplasma bovis NADH oxidase functions as both a NADH oxidizing and O2 reducing enzyme and an adhesin. Sci Rep. 2017;7(1):44. https://doi.org/10.1038/s41598-017-00121-y.
Song Z, Li Y, Liu Y, Xin J, Zou X, Sun W. alpha-Enolase, an adhesion-related factor of Mycoplasma bovis. PLoS One. 2012;7(6):e38836. https://doi.org/10.1371/journal.pone.0038836.
Raymond BBA, Madhkoor R, Schleicher I, Uphoff CC, Turnbull L, Whitchurch CB, et al. Extracellular actin is a receptor for Mycoplasma hyopneumoniae. Front Cell Infect Microbiol. 2018;8:54. https://doi.org/10.3389/fcimb.2018.00054.
Sokoli A, Groebel K, Hoelzle K, Amselgruber WM, Mateos JM, Schneider MK, et al. Mycoplasma suis infection results endothelial cell damage and activation: new insight into the cell tropism and pathogenicity of hemotrophic mycoplasma. Vet Res. 2013;44:6–12. https://doi.org/10.1186/1297-9716-44-6.
Chen R, Yu Y, Feng Z, Gan R, Xie X, Zhang Z, et al. Featured species-specific loops are found in the crystal structure of Mhp Eno, a cell surface adhesin from Mycoplasma hyopneumoniae. Front Cell Infect Microbiol. 2019;9:209. https://doi.org/10.3389/fcimb.2019.00209.
Hoelzle LE, Hoelzle K, Helbling M, Aupperle H, Schoon HA, Ritzmann M, et al. MSG1, a surface-localised protein of Mycoplasma suis is involved in the adhesion to erythrocytes. Microbes Infect. 2007;9(4):466–74. https://doi.org/10.1016/j.micinf.2007.01.004.
Schreiner SA, Sokoli A, Felder KM, Wittenbrink MM, Schwarzenbach S, Guhl B, et al. The surface-localised alpha-enolase of Mycoplasma suis is an adhesion protein. Vet Microbiol. 2012;156(1–2):88–95. https://doi.org/10.1016/j.vetmic.2011.10.010.
Song Q, Song W, Zhang W, He L, Fang R, Zhou Y, et al. Identification of erythrocyte membrane proteins interacting with Mycoplasma suis GAPDH and OSGEP. Res Vet Sci. 2018;119:85–90. https://doi.org/10.1016/j.rvsc.2018.05.001.
Widjaja M, Harvey KL, Hagemann L, Berry IJ, Jarocki VM, Raymond BBA, et al. Elongation factor Tu is a multifunctional and processed moonlighting protein. Sci Rep. 2017;7(1):11227. https://doi.org/10.1038/s41598-017-10644-z.
Kumar A, Alam A, Rani M, Ehtesham NZ, Hasnain SE. Biofilms: survival and defense strategy for pathogens. Int J Med Microbiol. 2017;307(8):481–9. https://doi.org/10.1016/j.ijmm.2017.09.016.
Roilides E, Simitsopoulou M, Katragkou A, Walsh TJ. How biofilms evade host defenses. Microbiol Spectr. 2015;3(3). https://doi.org/10.1128/microbiolspec.MB-0012-2014.
McAuliffe L, Ellis RJ, Miles K, Ayling RD, Nicholas RA. Biofilm formation by mycoplasma species and its role in environmental persistence and survival. Microbiology. 2006;152(Pt 4):913–22. https://doi.org/10.1099/mic.0.28604-0.
Raymond BBA, Jenkins C, Turnbull L, Whitchurch CB, Djordjevic SP. Extracellular DNA release from the genome-reduced pathogen Mycoplasma hyopneumoniae is essential for biofilm formation on abiotic surfaces. Sci Rep. 2018;8(1):10373. https://doi.org/10.1038/s41598-018-28678-2.
Tassew DD, Mechesso AF, Park NH, Song JB, Shur JW, Park SC. Biofilm formation and determination of minimum biofilm eradication concentration of antibiotics in Mycoplasma hyopneumoniae. J Vet Med Sci. 2017;79(10):1716–20. https://doi.org/10.1292/jvms.17-0279.
Funding
Open Access funding provided by Projekt DEAL.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Bacteriology
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hoelzle, K., Ade, J. & Hoelzle, L.E. Persistence in Livestock Mycoplasmas—a Key Role in Infection and Pathogenesis. Curr Clin Micro Rpt 7, 81–89 (2020). https://doi.org/10.1007/s40588-020-00149-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40588-020-00149-1